These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31293179)

  • 1. Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing.
    Wang Y; Liu L; Chen Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2820-2829. PubMed ID: 31293179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z; Li F; He S; Zhao L; Wang F
    Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
    Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing Analysis of mRNA Profile in Cisplatin-Resistant Gastric Cancer Cell Line SGC7901.
    Deng Z; Wang H; Guo G; Li X; Cai Y; Tang Y; Wang Y; Li J; Lu Z; Yu X; Li R; Li L
    Med Sci Monit; 2019 Apr; 25():2386-2396. PubMed ID: 30938333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
    Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
    Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
    Wang N; Hou MS; Zhan Y; Shen XB; Xue HY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7653-7659. PubMed ID: 30536307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
    Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
    Duan W; Liu X
    Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
    Li X; Zhao J; Yan T; Mu J; Lin Y; Chen J; Deng H; Meng X
    J Food Sci; 2021 Jun; 86(6):2700-2712. PubMed ID: 33908630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
    Cai L; Wang Z; Liu D
    Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.
    Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AJUBA increases the cisplatin resistance through hippo pathway in cervical cancer.
    Bi L; Ma F; Tian R; Zhou Y; Lan W; Song Q; Cheng X
    Gene; 2018 Feb; 644():148-154. PubMed ID: 29126926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome Profiling of Cisplatin Resistance in Triple-negative Breast Cancer: New Insight into the Role of PI3k/Akt Pathway.
    Memar M; Farazmandfar T; Sabaghian A; Shahbazi M; Golalipour M
    Curr Mol Med; 2023; 23(6):559-568. PubMed ID: 35585821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells.
    Zhang Y; Bao C; Mu Q; Chen J; Wang J; Mi Y; Sayari AJ; Chen Y; Guo M
    Neoplasma; 2016; 63(3):362-70. PubMed ID: 26925782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.
    Shu XR; Wu J; Sun H; Chi LQ; Wang JH
    Diagn Pathol; 2015 Sep; 10():177. PubMed ID: 26411419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cisplatin inhibits proliferation of cervical carcinoma cell line by up-regulating Stat1 expression].
    Lei RL; Xiao SS; Xue M
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):88-92. PubMed ID: 25613616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.